Hedge Fund - Polaris Capital Management
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $7.66 |
| 2 | 2019 - Q2 (2019-06-30) | $24,192,000 | 1.02% | 2,620,978 | $12.06 |
| 3 | 2019 - Q1 (2019-03-31) | $160,118,000 | 6.66% | 10,211,580 | $17.63 |
| 4 | 2018 - Q4 (2018-12-31) | $159,489,000 | 7.3% | 10,342,980 | $20.50 |
| 5 | 2018 - Q3 (2018-09-30) | $213,484,000 | 9.29% | 9,911,038 | $23.22 |
| 6 | 2018 - Q2 (2018-06-30) | $221,144,000 | 10.22% | 9,093,074 | $20.39 |
| 7 | 2018 - Q1 (2018-03-31) | $167,897,000 | 6.19% | 9,824,274 | $19.52 |
| 8 | 2017 - Q4 (2017-12-31) | $169,165,000 | 7.9% | 8,926,906 | $15.04 |
| 9 | 2017 - Q3 (2017-09-30) | $70,177,000 | 3.92% | 3,987,337 | $22.50 |
| 10 | 2017 - Q2 (2017-06-30) | $113,849,000 | 6.7% | 3,427,137 | $30.95 |
| 11 | 2017 - Q1 (2017-03-31) | $67,394,000 | 4.79% | 2,100,147 | $34.13 |
| 12 | 2016 - Q4 (2016-12-31) | $71,222,000 | 4.6% | 1,964,747 | $39.93 |
| 13 | 2016 - Q3 (2016-09-30) | $82,512,000 | 6.42% | 1,793,347 | $52.17 |
| 14 | 2016 - Q2 (2016-06-30) | $91,805,000 | 7.97% | 1,827,684 | $53.24 |
| 15 | 2016 - Q1 (2016-03-31) | $96,599,000 | 8.3% | 1,774,084 | $58.67 |
| 16 | 2015 - Q4 (2015-12-31) | $118,228,000 | 11.97% | 1,801,159 | $61.80 |
| 17 | 2015 - Q3 (2015-09-30) | $96,622,000 | 11.7% | 1,711,331 | $64.84 |
| 18 | 2015 - Q2 (2015-06-30) | $99,284,000 | 12.18% | 1,679,931 | $61.69 |
| 19 | 2015 - Q1 (2015-03-31) | $102,529,000 | 14.31% | 1,645,731 | $58.14 |
| 20 | 2014 - Q4 (2014-12-31) | $102,133,000 | 17.11% | 1,775,931 | $55.71 |
| 21 | 2014 - Q3 (2014-09-30) | $87,367,000 | 17.74% | 1,625,431 | $52.98 |
| 22 | 2014 - Q2 (2014-06-30) | $80,461,000 | 18.15% | 1,534,931 | $51.11 |
| 23 | 2014 - Q1 (2014-03-31) | $81,148,000 | 18.75% | 1,897,131 | $46.22 |
| 24 | 2013 - Q4 (2013-12-31) | $60,562,000 | 15.12% | 1,511,031 | $39.38 |
| 25 | 2013 - Q3 (2013-09-30) | $51,263,000 | 10.93% | 1,356,880 | $39.01 |
| 26 | 2013 - Q2 (2013-06-30) | $93,701,000 | 5.27% | 2,390,353 | $38.94 |
| 27 | 2013 - Q1 (2013-03-31) | $88,092,000 | 5.17% | 2,220,053 | $38.59 |
| 28 | 2012 - Q4 (2012-12-31) | $65,410,000 | 4.64% | 1,751,753 | $39.91 |
| 29 | 2012 - Q3 (2012-09-30) | $70,947,000 | 5.03% | 1,713,286 | $40.44 |
| 30 | 2012 - Q1 (2012-03-31) | $73,952,000 | 5.81% | 1,641,186 | $44.59 |
| 31 | 2011 - Q4 (2011-12-31) | $58,411,000 | 4.97% | 1,447,246 | $33.60 |
| 32 | 2011 - Q3 (2011-09-30) | $53,599,000 | 5.35% | 1,440,051 | $35.08 |
| 33 | 2011 - Q2 (2011-06-30) | $60,958,000 | 5.59% | 1,264,159 | $40.62 |
The displayed share prices are average quarterly stock market prices.